ID   MYO1C_HUMAN             Reviewed;        1063 AA.
AC   O00159; Q4LE56; Q6NVJ7; Q86Y95;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 4.
DT   22-JUL-2015, entry version 155.
DE   RecName: Full=Unconventional myosin-Ic;
DE   AltName: Full=Myosin I beta;
DE            Short=MMI-beta;
DE            Short=MMIb;
GN   Name=MYO1C;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANTS ILE-795 AND
RP   ARG-826.
RC   TISSUE=Kidney;
RX   PubMed=9119401; DOI=10.1006/geno.1996.4526;
RA   Crozet F., El-Amraoui A., Blanchard S., Lenoir M., Ripoll C., Vago P.,
RA   Hamel C., Fizames C., Levi-Acobas F., Depetris D., Mattei M.-G.,
RA   Weil D., Pujol R., Petit C.;
RT   "Cloning of the genes encoding two murine and human cochlear
RT   unconventional type I myosins.";
RL   Genomics 40:332-341(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS
RP   ILE-795 AND ARG-826.
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS
RP   ILE-795 AND ARG-826.
RA   Nakajima D., Saito K., Yamakawa H., Kikuno R.F., Nakayama M.,
RA   Ohara R., Okazaki N., Koga H., Nagase T., Ohara O.;
RT   "Preparation of a set of expression-ready clones of mammalian long
RT   cDNAs encoding large proteins by the ORF trap cloning method.";
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND
RP   VARIANTS ILE-795 AND ARG-826.
RC   TISSUE=Eye, and Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-206 (ISOFORM 3).
RC   TISSUE=Teratocarcinoma;
RA   Strausberg R.L.;
RL   Submitted (OCT-2002) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   PROTEIN SEQUENCE OF 36-43; 92-98; 104-125; 133-146; 172-188; 198-209;
RP   255-269; 341-350; 357-396; 400-412; 562-568; 606-624; 633-643;
RP   648-656; 666-674; 715-734; 814-822; 827-841; 875-884; 886-894;
RP   901-930; 937-956 AND 988-1047, ACETYLATION AT MET-1 (ISOFORM 2),
RP   METHYLATION AT LYS-383, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RA   Bienvenut W.V., Calvo F.;
RL   Submitted (FEB-2008) to UniProtKB.
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=16133118; DOI=10.1007/s00418-005-0042-8;
RA   Kysela K., Philimonenko A.A., Philimonenko V.V., Janacek J., Kahle M.,
RA   Hozak P.;
RT   "Nuclear distribution of actin and myosin I depends on transcriptional
RT   activity of the cell.";
RL   Histochem. Cell Biol. 124:347-358(2005).
RN   [9]
RP   INTERACTION WITH RPS6 AND ACTIN, AND SUBCELLULAR LOCATION.
RX   PubMed=16877530; DOI=10.1096/fj.05-5278fje;
RA   Cisterna B., Necchi D., Prosperi E., Biggiogera M.;
RT   "Small ribosomal subunits associate with nuclear myosin and actin in
RT   transit to the nuclear pores.";
RL   FASEB J. 20:1901-1903(2006).
RN   [10]
RP   IDENTIFICATION IN THE B-WICH COMPLEX.
RX   PubMed=16603771; DOI=10.1074/jbc.M600233200;
RA   Cavellan E., Asp P., Percipalle P., Oestlund Farrants A.-K.;
RT   "The WSTF-SNF2h chromatin remodeling complex interacts with several
RT   nuclear proteins in transcription.";
RL   J. Biol. Chem. 281:16264-16271(2006).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-408, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-408, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   ALTERNATIVE SPLICING (ISOFORM 1), AND SUBCELLULAR LOCATION (ISOFORM
RP   1).
RX   PubMed=22736583; DOI=10.1002/cm.21040;
RA   Ihnatovych I., Migocka-Patrzalek M., Dukh M., Hofmann W.A.;
RT   "Identification and characterization of a novel myosin Ic isoform that
RT   localizes to the nucleus.";
RL   Cytoskeleton 69:555-565(2012).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1 (ISOFORM 2), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.74 ANGSTROMS) OF 36-760 (ISOFORM 2) IN
RP   COMPLEX WITH ADP ORTHOVANADATE AND CALM, INTERACTION WITH CALM AND
RP   YWHAB, FUNCTION, ACTIN-BINDING, FUNCTION IN ACTIN-DEPENDENT ATP
RP   HYDROLYSIS, AND MUTAGENESIS OF SER-736.
RX   PubMed=24636949; DOI=10.1016/j.jmb.2014.03.004;
RA   Stefan Munnich M.H., Manstein D.J.;
RT   "Crystal structure of human myosin 1c - the motor in GLUT4 exocytosis:
RT   implications for Ca(2+)-regulation and 14-3-3 binding.";
RL   J. Mol. Biol. 426:2070-2081(2014).
CC   -!- FUNCTION: Myosins are actin-based motor molecules with ATPase
CC       activity. Unconventional myosins serve in intracellular movements.
CC       Their highly divergent tails are presumed to bind to membranous
CC       compartments, which would be moved relative to actin filaments.
CC       Involved in glucose transporter recycling in response to insulin
CC       by regulating movement of intracellular GLUT4-containing vesicles
CC       to the plasma membrane. Component of the hair cell's (the sensory
CC       cells of the inner ear) adaptation-motor complex. Acts as a
CC       mediator of adaptation of mechanoelectrical transduction in
CC       stereocilia of vestibular hair cells. Binds phosphoinositides and
CC       links the actin cytoskeleton to cellular membranes.
CC       {ECO:0000269|PubMed:24636949}.
CC   -!- FUNCTION: Isoform 3 is involved in regulation of transcription.
CC       Associated with transcriptional active ribosomal genes. Appears to
CC       cooperate with the WICH chromatin-remodeling complex to facilitate
CC       transcription. Necessary for the formation of the first
CC       phosphodiester bond during transcription initiation (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with GLUT4 (By similarity). Interacts (via its
CC       IQ motifs) with CABP1 and CIB1; the interaction with CABP1 and
CC       CIB1 is calcium-dependent. Interacts (via tail domain) with
CC       PLEKHB1 (via PH domain); the interaction is not affected by the
CC       presence or absence of calcium and CALM. Interacts with POLR1A and
CC       POLR2A. Component of the B-WICH complex, at least composed of
CC       SMARCA5/SNF2H, BAZ1B/WSTF, SF3B1, DEK, MYO1C, ERCC6, MYBBP1A and
CC       DDX21. Interacts (via its IQ motifs) with CALM; this precludes
CC       interaction with YWHAB. Interacts with YWHAB; this precludes
CC       interaction with CALM. Interacts with RPS6 and actin.
CC       {ECO:0000250, ECO:0000269|PubMed:16603771,
CC       ECO:0000269|PubMed:16877530, ECO:0000269|PubMed:24636949}.
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Cytoplasm
CC       {ECO:0000269|PubMed:22736583}. Nucleus
CC       {ECO:0000269|PubMed:22736583}. Note=Colocalizes with RNA
CC       polymerase II. Absent from nucleoli and does not colocalize with
CC       RNA polymerase I. Translocates to nuclear speckles upon exposure
CC       to inhibitors of RNA polymerase II transcription.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Cytoplasm. Cell membrane
CC       {ECO:0000250}; Peripheral membrane protein {ECO:0000250};
CC       Cytoplasmic side {ECO:0000250}. Cell projection, stereocilium
CC       membrane {ECO:0000250}. Cell projection, ruffle {ECO:0000250}.
CC       Cytoplasmic vesicle {ECO:0000250}. Note=Colocalizes with CABP1 and
CC       CIB1 at cell margin, membrane ruffles and punctate regions on the
CC       cell membrane. Colocalizes in adipocytes with GLUT4 at actin-based
CC       membranes. Colocalizes with GLUT4 at insulin-induced ruffles at
CC       the cell membrane. Localizes transiently at cell membrane to
CC       region known to be enriched in PIP2. Activation of phospholipase C
CC       results in its redistribution to the cytoplasm (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Isoform 3: Nucleus, nucleoplasm. Nucleus,
CC       nucleolus. Nucleus, nuclear pore complex. Note=Colocalizes with
CC       RNA polymerase II in the nucleus. Colocalizes with RNA polymerase
CC       I in nucleoli (By similarity). In the nucleolus, is localized
CC       predominantly in dense fibrillar component (DFC) and in granular
CC       component (GC). Accumulates strongly in DFC and GC during
CC       activation of transcription. Colocalizes with transcription sites.
CC       Colocalizes in the granular cortex at the periphery of the
CC       nucleolus with RPS6. Colocalizes in nucleoplasm with RPS6 and
CC       actin that are in contact with RNP particles. Colocalizes with
CC       RPS6 at the nuclear pore level. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=A;
CC         IsoId=O00159-1; Sequence=Displayed;
CC       Name=2; Synonyms=C;
CC         IsoId=O00159-2; Sequence=VSP_036861;
CC         Note=Contains a N-acetylmethionine at position 1.
CC         {ECO:0000269|PubMed:22814378};
CC       Name=3; Synonyms=B, Nuclear myosin 1, NM1, NMI;
CC         IsoId=O00159-3; Sequence=VSP_036862;
CC   -!- DOMAIN: Binds directly to large unilamellar vesicles (LUVs)
CC       containing phosphatidylinositol 4,5-bisphosphate (PIP2) or
CC       inositol 1,4,5-trisphosphate (InsP3). The PIP2-binding site
CC       corresponds to the myosin tail domain (PH-like) present in its
CC       tail domain (By similarity). {ECO:0000250}.
CC   -!- PTM: Isoform 2 contains a N-acetylmethionine at position 1.
CC   -!- SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase
CC       superfamily. Myosin family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 2 IQ domains. {ECO:0000255|PROSITE-
CC       ProRule:PRU00116}.
CC   -!- SIMILARITY: Contains 1 myosin motor domain. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 TH1 (class I myosin tail homology) domain.
CC       {ECO:0000255|PROSITE-ProRule:PRU01093}.
CC   -!- CAUTION: Represents an unconventional myosin. This protein should
CC       not be confused with the conventional myosin-1 (MYH1).
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH68013.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAE06097.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=BAF85599.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X98507; CAA67131.1; -; mRNA.
DR   EMBL; AK292910; BAF85599.1; ALT_INIT; mRNA.
DR   EMBL; AB210015; BAE06097.1; ALT_INIT; mRNA.
DR   EMBL; AC100748; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC044891; AAH44891.2; -; mRNA.
DR   EMBL; BC068013; AAH68013.1; ALT_INIT; mRNA.
DR   EMBL; BU855623; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS11003.1; -. [O00159-2]
DR   CCDS; CCDS42226.1; -. [O00159-1]
DR   CCDS; CCDS45562.1; -. [O00159-3]
DR   PIR; A59253; A59253.
DR   RefSeq; NP_001074248.1; NM_001080779.1. [O00159-1]
DR   RefSeq; NP_001074419.1; NM_001080950.1. [O00159-3]
DR   RefSeq; NP_203693.3; NM_033375.4. [O00159-2]
DR   UniGene; Hs.286226; -.
DR   PDB; 4BYF; X-ray; 2.74 A; A/C=36-760.
DR   PDBsum; 4BYF; -.
DR   ProteinModelPortal; O00159; -.
DR   SMR; O00159; 44-1060.
DR   BioGrid; 110725; 39.
DR   DIP; DIP-33109N; -.
DR   IntAct; O00159; 18.
DR   MINT; MINT-1149702; -.
DR   STRING; 9606.ENSP00000352834; -.
DR   PhosphoSite; O00159; -.
DR   BioMuta; MYO1C; -.
DR   MaxQB; O00159; -.
DR   PaxDb; O00159; -.
DR   PeptideAtlas; O00159; -.
DR   PRIDE; O00159; -.
DR   Ensembl; ENST00000359786; ENSP00000352834; ENSG00000197879.
DR   Ensembl; ENST00000361007; ENSP00000354283; ENSG00000197879. [O00159-2]
DR   Ensembl; ENST00000438665; ENSP00000412197; ENSG00000197879. [O00159-3]
DR   Ensembl; ENST00000575158; ENSP00000459174; ENSG00000197879. [O00159-2]
DR   GeneID; 4641; -.
DR   KEGG; hsa:4641; -.
DR   UCSC; uc002fsn.3; human. [O00159-3]
DR   UCSC; uc002fso.3; human. [O00159-1]
DR   CTD; 4641; -.
DR   GeneCards; GC17M001367; -.
DR   H-InvDB; HIX0202539; -.
DR   HGNC; HGNC:7597; MYO1C.
DR   HPA; CAB037023; -.
DR   HPA; HPA001768; -.
DR   MIM; 606538; gene.
DR   neXtProt; NX_O00159; -.
DR   Orphanet; 90635; Autosomal dominant non-syndromic sensorineural deafness type DFNA.
DR   PharmGKB; PA31399; -.
DR   eggNOG; COG5022; -.
DR   GeneTree; ENSGT00760000118956; -.
DR   HOGENOM; HOG000260264; -.
DR   InParanoid; O00159; -.
DR   KO; K10356; -.
DR   OMA; YAETCPA; -.
DR   OrthoDB; EOG7V49XQ; -.
DR   PhylomeDB; O00159; -.
DR   TreeFam; TF312960; -.
DR   Reactome; REACT_147867; Translocation of GLUT4 to the plasma membrane.
DR   Reactome; REACT_160086; Regulation of actin dynamics for phagocytic cup formation.
DR   ChiTaRS; MYO1C; human.
DR   GeneWiki; MYO1C; -.
DR   GenomeRNAi; 4641; -.
DR   NextBio; 17880; -.
DR   PRO; PR:O00159; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; O00159; -.
DR   CleanEx; HS_MYO1C; -.
DR   ExpressionAtlas; O00159; baseline and differential.
DR   Genevisible; O00159; HS.
DR   GO; GO:0009925; C:basal plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005903; C:brush border; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0016023; C:cytoplasmic membrane-bounded vesicle; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0031941; C:filamentous actin; IDA:UniProtKB.
DR   GO; GO:0016328; C:lateral plasma membrane; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0045121; C:membrane raft; IDA:UniProtKB.
DR   GO; GO:0005902; C:microvillus; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0045160; C:myosin I complex; IEA:Ensembl.
DR   GO; GO:0005643; C:nuclear pore; IEA:UniProtKB-SubCell.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0001726; C:ruffle; IEA:UniProtKB-SubCell.
DR   GO; GO:0060171; C:stereocilium membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016461; C:unconventional myosin complex; TAS:UniProtKB.
DR   GO; GO:0030898; F:actin-dependent ATPase activity; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003774; F:motor activity; IEA:InterPro.
DR   GO; GO:0017160; F:Ral GTPase binding; IPI:UniProtKB.
DR   GO; GO:0005102; F:receptor binding; IPI:UniProtKB.
DR   GO; GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome.
DR   GO; GO:0045087; P:innate immune response; TAS:Reactome.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   GO; GO:0051028; P:mRNA transport; IEA:UniProtKB-KW.
DR   GO; GO:0030335; P:positive regulation of cell migration; IMP:UniProtKB.
DR   GO; GO:0038089; P:positive regulation of cell migration by vascular endothelial growth factor signaling pathway; IMP:UniProtKB.
DR   GO; GO:0090314; P:positive regulation of protein targeting to membrane; IMP:UniProtKB.
DR   GO; GO:1900748; P:positive regulation of vascular endothelial growth factor signaling pathway; IMP:UniProtKB.
DR   GO; GO:0006605; P:protein targeting; IDA:UniProtKB.
DR   GO; GO:0006612; P:protein targeting to membrane; IDA:UniProtKB.
DR   GO; GO:2000810; P:regulation of bicellular tight junction assembly; IMP:UniProtKB.
DR   InterPro; IPR000048; IQ_motif_EF-hand-BS.
DR   InterPro; IPR001609; Myosin_head_motor_dom.
DR   InterPro; IPR010926; Myosin_tail_2.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF00612; IQ; 2.
DR   Pfam; PF00063; Myosin_head; 1.
DR   Pfam; PF06017; Myosin_TH1; 1.
DR   PRINTS; PR00193; MYOSINHEAVY.
DR   SMART; SM00015; IQ; 3.
DR   SMART; SM00242; MYSc; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS50096; IQ; 2.
DR   PROSITE; PS51456; MYOSIN_MOTOR; 1.
DR   PROSITE; PS51757; TH1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Actin-binding; Alternative splicing;
KW   ATP-binding; Calmodulin-binding; Cell membrane; Cell projection;
KW   Complete proteome; Cytoplasm; Cytoplasmic vesicle;
KW   Direct protein sequencing; Membrane; Methylation; Motor protein;
KW   mRNA transport; Myosin; Nuclear pore complex; Nucleotide-binding;
KW   Nucleus; Phosphoprotein; Polymorphism; Protein transport;
KW   Reference proteome; Repeat; Translocation; Transport.
FT   CHAIN         1   1063       Unconventional myosin-Ic.
FT                                /FTId=PRO_0000123445.
FT   DOMAIN       47    731       Myosin motor.
FT   DOMAIN      734    757       IQ 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00116}.
FT   DOMAIN      758    786       IQ 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00116}.
FT   DOMAIN      885   1059       TH1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01093}.
FT   NP_BIND     139    148       ATP.
FT   NP_BIND     192    196       ATP.
FT   BINDING      88     88       ATP.
FT   BINDING      96     96       ATP.
FT   MOD_RES     383    383       N6-methyllysine. {ECO:0000269|Ref.7}.
FT   MOD_RES     408    408       Phosphoserine.
FT                                {ECO:0000269|PubMed:18669648,
FT                                ECO:0000269|PubMed:20068231}.
FT   MOD_RES     486    486       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9WTI7}.
FT   VAR_SEQ       1     35       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9119401}.
FT                                /FTId=VSP_036861.
FT   VAR_SEQ       1     25       MALQVELVPTGEIIRVVHPHRPCKL -> MRYRAS (in
FT                                isoform 3). {ECO:0000303|Ref.6}.
FT                                /FTId=VSP_036862.
FT   VARIANT     795    795       V -> I (in dbSNP:rs8081370).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:9119401,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_054855.
FT   VARIANT     826    826       Q -> R (in dbSNP:rs9905106).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:9119401,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_054856.
FT   MUTAGEN     736    736       S->A: Abolishes interaction with YWHAB.
FT                                {ECO:0000269|PubMed:24636949}.
FT   MUTAGEN     736    736       S->E: Increases affinity for YWHAB.
FT                                {ECO:0000269|PubMed:24636949}.
FT   CONFLICT     37     37       E -> D (in Ref. 1; CAA67131).
FT                                {ECO:0000305}.
FT   CONFLICT    152    152       R -> K (in Ref. 1; CAA67131).
FT                                {ECO:0000305}.
FT   CONFLICT    165    165       E -> Q (in Ref. 1; CAA67131).
FT                                {ECO:0000305}.
FT   CONFLICT    200    200       K -> E (in Ref. 6; BU855623).
FT                                {ECO:0000305}.
FT   CONFLICT    324    324       E -> D (in Ref. 1; CAA67131).
FT                                {ECO:0000305}.
FT   CONFLICT    379    379       D -> N (in Ref. 1; CAA67131).
FT                                {ECO:0000305}.
FT   CONFLICT    453    453       T -> P (in Ref. 1; CAA67131).
FT                                {ECO:0000305}.
FT   CONFLICT    832    832       S -> Y (in Ref. 1; CAA67131).
FT                                {ECO:0000305}.
FT   CONFLICT    986    986       N -> I (in Ref. 1; CAA67131).
FT                                {ECO:0000305}.
FT   CONFLICT   1062   1062       S -> Y (in Ref. 1; CAA67131).
FT                                {ECO:0000305}.
FT   HELIX        51     53       {ECO:0000244|PDB:4BYF}.
FT   HELIX        60     72       {ECO:0000244|PDB:4BYF}.
FT   STRAND       77     80       {ECO:0000244|PDB:4BYF}.
FT   STRAND       83     87       {ECO:0000244|PDB:4BYF}.
FT   HELIX        98    104       {ECO:0000244|PDB:4BYF}.
FT   HELIX       109    111       {ECO:0000244|PDB:4BYF}.
FT   HELIX       116    129       {ECO:0000244|PDB:4BYF}.
FT   STRAND      134    139       {ECO:0000244|PDB:4BYF}.
FT   HELIX       146    160       {ECO:0000244|PDB:4BYF}.
FT   HELIX       170    185       {ECO:0000244|PDB:4BYF}.
FT   STRAND      193    196       {ECO:0000244|PDB:4BYF}.
FT   STRAND      198    206       {ECO:0000244|PDB:4BYF}.
FT   STRAND      212    220       {ECO:0000244|PDB:4BYF}.
FT   HELIX       225    227       {ECO:0000244|PDB:4BYF}.
FT   HELIX       238    246       {ECO:0000244|PDB:4BYF}.
FT   HELIX       249    254       {ECO:0000244|PDB:4BYF}.
FT   HELIX       261    263       {ECO:0000244|PDB:4BYF}.
FT   TURN        265    267       {ECO:0000244|PDB:4BYF}.
FT   STRAND      269    271       {ECO:0000244|PDB:4BYF}.
FT   HELIX       280    293       {ECO:0000244|PDB:4BYF}.
FT   HELIX       298    316       {ECO:0000244|PDB:4BYF}.
FT   HELIX       333    342       {ECO:0000244|PDB:4BYF}.
FT   HELIX       346    354       {ECO:0000244|PDB:4BYF}.
FT   STRAND      355    357       {ECO:0000244|PDB:4BYF}.
FT   STRAND      366    368       {ECO:0000244|PDB:4BYF}.
FT   HELIX       371    401       {ECO:0000244|PDB:4BYF}.
FT   STRAND      408    413       {ECO:0000244|PDB:4BYF}.
FT   STRAND      415    421       {ECO:0000244|PDB:4BYF}.
FT   STRAND      429    431       {ECO:0000244|PDB:4BYF}.
FT   HELIX       433    453       {ECO:0000244|PDB:4BYF}.
FT   HELIX       455    464       {ECO:0000244|PDB:4BYF}.
FT   HELIX       477    484       {ECO:0000244|PDB:4BYF}.
FT   TURN        486    488       {ECO:0000244|PDB:4BYF}.
FT   HELIX       490    496       {ECO:0000244|PDB:4BYF}.
FT   STRAND      499    503       {ECO:0000244|PDB:4BYF}.
FT   HELIX       506    516       {ECO:0000244|PDB:4BYF}.
FT   STRAND      528    530       {ECO:0000244|PDB:4BYF}.
FT   STRAND      535    537       {ECO:0000244|PDB:4BYF}.
FT   STRAND      539    546       {ECO:0000244|PDB:4BYF}.
FT   STRAND      549    554       {ECO:0000244|PDB:4BYF}.
FT   HELIX       558    562       {ECO:0000244|PDB:4BYF}.
FT   HELIX       568    575       {ECO:0000244|PDB:4BYF}.
FT   HELIX       580    585       {ECO:0000244|PDB:4BYF}.
FT   HELIX       600    616       {ECO:0000244|PDB:4BYF}.
FT   STRAND      618    626       {ECO:0000244|PDB:4BYF}.
FT   HELIX       639    649       {ECO:0000244|PDB:4BYF}.
FT   HELIX       651    660       {ECO:0000244|PDB:4BYF}.
FT   STRAND      663    667       {ECO:0000244|PDB:4BYF}.
FT   HELIX       668    675       {ECO:0000244|PDB:4BYF}.
FT   HELIX       676    678       {ECO:0000244|PDB:4BYF}.
FT   STRAND      682    684       {ECO:0000244|PDB:4BYF}.
FT   HELIX       690    701       {ECO:0000244|PDB:4BYF}.
FT   STRAND      707    710       {ECO:0000244|PDB:4BYF}.
FT   STRAND      712    718       {ECO:0000244|PDB:4BYF}.
FT   HELIX       720    753       {ECO:0000244|PDB:4BYF}.
SQ   SEQUENCE   1063 AA;  121682 MW;  B105197BA07317B8 CRC64;
     MALQVELVPT GEIIRVVHPH RPCKLALGSD GVRVTMESAL TARDRVGVQD FVLLENFTSE
     AAFIENLRRR FRENLIYTYI GPVLVSVNPY RDLQIYSRQH MERYRGVSFY EVPPHLFAVA
     DTVYRALRTE RRDQAVMISG ESGAGKTEAT KRLLQFYAET CPAPERGGAV RDRLLQSNPV
     LEAFGNAKTL RNDNSSRFGK YMDVQFDFKG APVGGHILSY LLEKSRVVHQ NHGERNFHIF
     YQLLEGGEEE TLRRLGLERN PQSYLYLVKG QCAKVSSIND KSDWKVVRKA LTVIDFTEDE
     VEDLLSIVAS VLHLGNIHFA ANEESNAQVT TENQLKYLTR LLSVEGSTLR EALTHRKIIA
     KGEELLSPLN LEQAAYARDA LAKAVYSRTF TWLVGKINRS LASKDVESPS WRSTTVLGLL
     DIYGFEVFQH NSFEQFCINY CNEKLQQLFI ELTLKSEQEE YEAEGIAWEP VQYFNNKIIC
     DLVEEKFKGI ISILDEECLR PGEATDLTFL EKLEDTVKHH PHFLTHKLAD QRTRKSLGRG
     EFRLLHYAGE VTYSVTGFLD KNNDLLFRNL KETMCSSKNP IMSQCFDRSE LSDKKRPETV
     ATQFKMSLLQ LVEILQSKEP AYVRCIKPND AKQPGRFDEV LIRHQVKYLG LLENLRVRRA
     GFAYRRKYEA FLQRYKSLCP ETWPTWAGRP QDGVAVLVRH LGYKPEEYKM GRTKIFIRFP
     KTLFATEDAL EVRRQSLATK IQAAWRGFHW RQKFLRVKRS AICIQSWWRG TLGRRKAAKR
     KWAAQTIRRL IRGFVLRHAP RCPENAFFLD HVRTSFLLNL RRQLPQNVLD TSWPTPPPAL
     REASELLREL CIKNMVWKYC RSISPEWKQQ LQQKAVASEI FKGKKDNYPQ SVPRLFISTR
     LGTDEISPRV LQALGSEPIQ YAVPVVKYDR KGYKPRSRQL LLTPNAVVIV EDAKVKQRID
     YANLTGISVS SLSDSLFVLH VQRADNKQKG DVVLQSDHVI ETLTKTALSA NRVNSININQ
     GSITFAGGPG RDGTIDFTPG SELLITKAKN GHLAVVAPRL NSR
//
